In this study, the administration of paclitaxel for the treatment of the spontaneous-TNBC analogue BRCA1/p53-deleted mouse model mammary tumors induced PD-L1 expression in the TAMs, thus leading to an immunosuppressive TME. The gene discussed is BRCA1; the disease is breast cancer.